[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE69019404D1 - Derivate von Penciclovir zur Behandlung von Hepatitis-B-Infektionen. - Google Patents

Derivate von Penciclovir zur Behandlung von Hepatitis-B-Infektionen.

Info

Publication number
DE69019404D1
DE69019404D1 DE69019404T DE69019404T DE69019404D1 DE 69019404 D1 DE69019404 D1 DE 69019404D1 DE 69019404 T DE69019404 T DE 69019404T DE 69019404 T DE69019404 T DE 69019404T DE 69019404 D1 DE69019404 D1 DE 69019404D1
Authority
DE
Germany
Prior art keywords
infections
penciclovir
derivatives used
treat hepatitis
hepatitis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69019404T
Other languages
English (en)
Other versions
DE69019404T2 (de
Inventor
Malcolm Richard Boyd
David Sutton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis International Pharmaceutical Ltd
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10652653&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69019404(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of DE69019404D1 publication Critical patent/DE69019404D1/de
Application granted granted Critical
Publication of DE69019404T2 publication Critical patent/DE69019404T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69019404T 1989-03-03 1990-03-01 Derivate von Penciclovir zur Behandlung von Hepatitis-B-Infektionen. Expired - Lifetime DE69019404T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898904855A GB8904855D0 (en) 1989-03-03 1989-03-03 Pharmaceutical treatment

Publications (2)

Publication Number Publication Date
DE69019404D1 true DE69019404D1 (de) 1995-06-22
DE69019404T2 DE69019404T2 (de) 1995-10-12

Family

ID=10652653

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69019404T Expired - Lifetime DE69019404T2 (de) 1989-03-03 1990-03-01 Derivate von Penciclovir zur Behandlung von Hepatitis-B-Infektionen.

Country Status (18)

Country Link
US (1) US6136813A (de)
EP (1) EP0388049B1 (de)
JP (1) JP2513519B2 (de)
KR (1) KR0143410B1 (de)
AT (1) ATE122562T1 (de)
AU (1) AU628137B2 (de)
CA (1) CA2011238C (de)
CY (1) CY1870A (de)
DE (1) DE69019404T2 (de)
DK (1) DK0388049T3 (de)
ES (1) ES2072386T3 (de)
GB (1) GB8904855D0 (de)
HK (1) HK116795A (de)
HU (1) HU205715B (de)
IE (1) IE67125B1 (de)
IL (1) IL93594A (de)
LV (1) LV10923B (de)
ZA (1) ZA901572B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6124304A (en) * 1993-10-05 2000-09-26 Smithkline Beecham Plc Penciclovir for the treatment of zoster associated pain
GB9326177D0 (en) * 1993-12-22 1994-02-23 Smithkline Beecham Plc Pharmaceuticals
WO1995022330A1 (en) * 1994-02-17 1995-08-24 Commonwealth Scientific And Industrial Research Organisation Antiviral agents
WO1996033720A1 (en) * 1995-04-24 1996-10-31 Smithkline Beecham Plc Use of (r)-penciclovir triphosphate for the manufacture of a medicament for the treatment of viral diseases
AU5127098A (en) * 1996-11-29 1998-06-22 Smithkline Beecham Plc Use of a combination of penciclovir and alpha-interferon in the manufacture of a medicament for the treatment of hepatitis
US5939423A (en) * 1997-04-16 1999-08-17 Sciclone Pharmaceuticals, Inc. Treatment of hepatitis B infection with thymosin alpha 1 and famciclovir
AUPO912997A0 (en) * 1997-09-11 1997-10-02 Commonwealth Scientific And Industrial Research Organisation Antiviral agents
US6288033B1 (en) 1998-09-25 2001-09-11 Sciclone Pharmaceuticals, Inc. Treatment of hepatitis B infection with thymosin alpha 1 in combination with lamivudine or in combination with lamivudine and famciclovir
AU1810600A (en) * 1998-11-02 2000-05-22 Triangle Pharmaceuticals, Inc. Combination therapy to treat hepatitis b virus
AU2013257951A1 (en) 2012-05-11 2015-01-22 Akron Molecules Ag Use of compounds for the treatment of pain

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4199574A (en) * 1974-09-02 1980-04-22 Burroughs Wellcome Co. Methods and compositions for treating viral infections and guanine acyclic nucleosides
US4230708A (en) * 1977-10-20 1980-10-28 Stichting Rega V.Z.W. Therapeutic application of (S) -or (RS)-9-(2, 3-dihydroxypropyl) adenine for use as antiviral agents
NL8202626A (nl) * 1982-06-29 1984-01-16 Stichting Rega V Z W Derivaten van 9-(2-hydroxyethoxymethyl)guanine.
US4556659A (en) * 1982-08-09 1985-12-03 Syntex (U.S.A.) Inc. Substituted 9-(1-0- or 3-0-monosubstituted or 1,3-Di-0-substituted propoxymethyl)-purines as antiviral agents
US5059604A (en) * 1982-10-14 1991-10-22 Burroughs Wellcome Co. 2-amino purine derivatives
US4649140A (en) * 1982-10-14 1987-03-10 Burroughs Wellcome Co. Purine derivatives
EP0141927B1 (de) * 1983-08-18 1991-10-30 Beecham Group Plc Antivirale Guanin-Derivate
IL73682A (en) * 1983-12-20 1991-08-16 Medivir Ab Antiviral pharmaceutical compositions containing 9-hydroxy aliphatic derivatives of guanine,some new such derivatives and process for their preparation
EP0182024B1 (de) * 1984-09-20 1991-04-03 Beecham Group Plc Purin-Derivate und ihre pharmazeutische Verwendung
SE8406538D0 (sv) * 1984-12-21 1984-12-21 Astra Laekemedel Ab Novel derivatives of purine
DE3671227D1 (de) * 1985-07-27 1990-06-21 Beecham Group Plc 9-substituierte guaninmonohydrate.
SE8602981D0 (sv) * 1986-07-04 1986-07-04 Astra Laekemedel Ab Novel medicinal use
HU196038B (en) * 1987-08-07 1988-09-28 Mta Koezponti Kemiai Kutato In Process for producing antiherpetic pharmaceutics for external use, containing 5-isopropyl-2'-beta-deoxy-uridine
SE8801729D0 (sv) * 1988-05-06 1988-05-06 Astra Ab Purine derivatives for use in therapy
GB8823320D0 (en) * 1988-10-05 1988-11-09 Nycomed As Chemical compounds

Also Published As

Publication number Publication date
IE900733L (en) 1990-09-03
IE67125B1 (en) 1996-03-06
DK0388049T3 (da) 1995-06-06
LV10923A (lv) 1995-12-20
AU5060090A (en) 1990-11-01
HUT53522A (en) 1990-11-28
AU628137B2 (en) 1992-09-10
JP2513519B2 (ja) 1996-07-03
HU205715B (en) 1992-06-29
CY1870A (en) 1996-04-05
IL93594A0 (en) 1990-12-23
HK116795A (en) 1995-07-21
ES2072386T3 (es) 1995-07-16
DE69019404T2 (de) 1995-10-12
ZA901572B (en) 1991-03-27
GB8904855D0 (en) 1989-04-12
CA2011238A1 (en) 1990-09-03
JPH02275821A (ja) 1990-11-09
HU901252D0 (en) 1990-05-28
CA2011238C (en) 2000-03-28
KR900014385A (ko) 1990-10-23
US6136813A (en) 2000-10-24
ATE122562T1 (de) 1995-06-15
LV10923B (en) 1996-06-20
EP0388049B1 (de) 1995-05-17
EP0388049A3 (de) 1991-11-06
KR0143410B1 (ko) 1998-07-15
EP0388049A2 (de) 1990-09-19
IL93594A (en) 1995-05-26

Similar Documents

Publication Publication Date Title
DK602988D0 (da) Nukleosidderivater med antiviral virkning og laegemiddelpraeparat indeholdende saadanne forbindelser
DE69223914D1 (de) 4-substituierte-2-Deoxy-2,3-Didehydro Alpha-D-Neuraminsäure antivirale Derivate
DE69206876D1 (de) Nukleosidanalogen enthaltende Antiviren-Zubereitungen
DE69019404D1 (de) Derivate von Penciclovir zur Behandlung von Hepatitis-B-Infektionen.
DK627987D0 (da) Farmaceutiske praeparater
DK707988D0 (da) Fremgangsmaade til at haemme virus
MC1930A1 (fr) Produit antiviral
ATE210445T1 (de) Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 7 infektionen
DE69619088D1 (de) Quinoxalin-Derivate zur Behandlung von Tinnitus
ATE210985T1 (de) Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 6 infektionen
BR9607663A (pt) Uso de penciclovir para o tratamento de herpes-virus 8 humano
ES2062266T3 (es) Uso de quinolil- e isoquinoliloxazol-2-onas para la obtencion de un medicamento destinado para la prevencion de infecciones por virus envueltos por glicoproteinas.
ATE30592T1 (de) Penicillinderivate.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD., HAMILT